SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-17-002675
Filing Date
2017-02-17
Accepted
2017-02-17 16:59:28
Documents
2
Period of Report
2017-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 6730
2 ex24hibbenek.txt EX-24 4982
  Complete submission text file 0001179110-17-002675.txt   13158
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG. 1400E B14202 CAMBRIDGE MA 02139
Business Address
Hibben Edward K. (Reporting) CIK: 0001697798 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 17622120